BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30992425)

  • 21. Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell.
    Si Y; Liu J; Shen H; Zhang C; Wu Y; Huang Y; Gong Z; Xue J; Liu T
    J Cell Mol Med; 2019 Feb; 23(2):1095-1105. PubMed ID: 30411496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin Y phosphorylation- and 14-3-3-binding-dependent activation of PCTAIRE-1/CDK16.
    Shehata SN; Deak M; Morrice NA; Ohta E; Hunter RW; Kalscheuer VM; Sakamoto K
    Biochem J; 2015 Aug; 469(3):409-20. PubMed ID: 26205494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plk1 negatively regulates PRC1 to prevent premature midzone formation before cytokinesis.
    Hu CK; Ozlü N; Coughlin M; Steen JJ; Mitchison TJ
    Mol Biol Cell; 2012 Jul; 23(14):2702-11. PubMed ID: 22621898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatiotemporal control of spindle midzone formation by PRC1 in human cells.
    Zhu C; Lau E; Schwarzenbacher R; Bossy-Wetzel E; Jiang W
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6196-201. PubMed ID: 16603632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK16 overexpressed in non-small cell lung cancer and regulates cancer cell growth and apoptosis via a p27-dependent mechanism.
    Wang H; Liu H; Min S; Shen Y; Li W; Chen Y; Wang X
    Biomed Pharmacother; 2018 Jul; 103():399-405. PubMed ID: 29674275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src-mediated tyrosine phosphorylation of PRC1 and kinastrin/SKAP on the mitotic spindle.
    Morii M; Kubota S; Hasegawa C; Takeda Y; Kometani S; Enomoto K; Suzuki T; Yanase S; Sato R; Akatsu A; Hirata K; Honda T; Kuga T; Tomonaga T; Nakayama Y; Yamaguchi N; Yamaguchi N
    Sci Rep; 2021 Jan; 11(1):2616. PubMed ID: 33510346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRC1 controls spindle polarization and recruitment of cytokinetic factors during monopolar cytokinesis.
    Shrestha S; Wilmeth LJ; Eyer J; Shuster CB
    Mol Biol Cell; 2012 Apr; 23(7):1196-207. PubMed ID: 22323288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus.
    Hanselmann S; Gertzmann D; Shin WJ; Ade CP; Gaubatz S
    Cell Cycle; 2023 Feb; 22(4):419-432. PubMed ID: 36135961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of cyclin Y by CDK14 induces its ubiquitination and degradation.
    Li S; Song W; Jiang M; Zeng L; Zhu X; Chen J
    FEBS Lett; 2014 May; 588(11):1989-96. PubMed ID: 24794231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Cdk targets that control cytokinesis.
    Kuilman T; Maiolica A; Godfrey M; Scheidel N; Aebersold R; Uhlmann F
    EMBO J; 2015 Jan; 34(1):81-96. PubMed ID: 25371407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3 Binding to Cyclin Y contributes to cyclin Y/CDK14 association.
    Li S; Jiang M; Wang W; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):299-304. PubMed ID: 24618387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.
    Yanagi T; Shi R; Aza-Blanc P; Reed JC; Matsuzawa S
    PLoS One; 2015; 10(3):e0119404. PubMed ID: 25790448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cyclin Y in normal and pathological cells.
    Opacka A; Żuryń A; Krajewski A; Mikołajczyk K
    Cell Cycle; 2023 Apr; 22(8):859-869. PubMed ID: 36576166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCTAIRE1/PCTK1/CDK16: a new oncotarget?
    Yanagi T; Matsuzawa S
    Cell Cycle; 2015; 14(4):463-4. PubMed ID: 25590439
    [No Abstract]   [Full Text] [Related]  

  • 35. KIF14 and citron kinase act together to promote efficient cytokinesis.
    Gruneberg U; Neef R; Li X; Chan EH; Chalamalasetty RB; Nigg EA; Barr FA
    J Cell Biol; 2006 Jan; 172(3):363-72. PubMed ID: 16431929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitotic phosphorylation of PRC1 at Thr470 is required for PRC1 oligomerization and proper central spindle organization.
    Fu C; Yan F; Wu F; Wu Q; Whittaker J; Hu H; Hu R; Yao X
    Cell Res; 2007 May; 17(5):449-57. PubMed ID: 17438553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.
    Wang Y; Qin X; Guo T; Liu P; Wu P; Liu Z
    J Exp Clin Cancer Res; 2017 Jul; 36(1):97. PubMed ID: 28716136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
    Neef R; Gruneberg U; Kopajtich R; Li X; Nigg EA; Sillje H; Barr FA
    Nat Cell Biol; 2007 Apr; 9(4):436-44. PubMed ID: 17351640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human mitotic spindle-associated protein PRC1 inhibits MgcRacGAP activity toward Cdc42 during the metaphase.
    Ban R; Irino Y; Fukami K; Tanaka H
    J Biol Chem; 2004 Apr; 279(16):16394-402. PubMed ID: 14744859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 3-Amino-1
    Amrhein JA; Berger LM; Tjaden A; Krämer A; Elson L; Tolvanen T; Martinez-Molina D; Kaiser A; Schubert-Zsilavecz M; Müller S; Knapp S; Hanke T
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.